MMR approval
THE Therapeutic Goods Administration has granted Section 19A approval for a new MMR (Measles-MumpsRubella) Vaccine, due to a current shortage of Australian registered products.
Details at tga.gov.au.
THE Therapeutic Goods Administration has granted Section 19A approval for a new MMR (Measles-MumpsRubella) Vaccine, due to a current shortage of Australian registered products.
Details at tga.gov.au.